Mikołaj Biegański

Mikołaj Biegański

Auto-generated profile, based on publicly available information

Mikołaj Biegański

Department of Histology and Embryology, Faculty of Medicine Warsaw Medical University Warsaw Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2024 in Pharmacological Reports
Verified
Journal Article
Open access
PDF file
MBMikołaj Biegański
Mikołaj Biegański
MSMonika Szeliga
Monika Szeliga
Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS). Gliomas, malignant brain tumors with a dismal prognosis, alter glutamate homeostasis in the brain, which is advantageous for their growth, survival, and invasion. Alterations in glutamate homeostasis result from its excessive production and release to the extracellular space. High glutamate concentration in the tumor microenvironment destroys healthy tissue surrounding the tumor, thus providing space for glioma cells to expand. Moreover, it confers neuron hyperexcitability, leading to epilepsy, a common symptom in glioma patients. This mini-review briefly describes the biochemistry of glutamate production and transport in gliomas as well as the activation of glutamate receptors. It also summarizes the current pre-clinical and clinical studies identifying pharmacotherapeutics targeting glutamate transporters and receptors emerging as potential therapeutic strategies for glioma.

11 November 2025 in Computational Biology and Chemistry
Verified
Journal Article
Closed access
MBMikołaj Biegański
Mikołaj Biegański
MBMarius Bidon
Marius Bidon
MKMonika Karpińska
Monika Karpińska
RRRadoslaw Rola
Radoslaw Rola
JMJoanna Matysiak
Joanna Matysiak
MSMonika Szeliga
Monika Szeliga

23 June 2026 in Cytometry Part A
Verified
Journal Article
Open access
PDF file
MMMaria V. Leyba Mesa
Maria V. Leyba Mesa
MBMikołaj Biegański
Mikołaj Biegański
ERElijah Ray
Elijah Ray
IMIzabela Mlynarczuk-Bialy
Izabela Mlynarczuk-Bialy
Buket BarkanaBuket Barkana
Buket Barkana
Cell‐in‐cell (CIC) structures are among the most intriguing cellular phenomena occasionally observed in human cancer specimens. Once regarded as incidental findings, accumulating evidence has linked specific CIC subtypes, particularly entosis, to tumor progression and patient prognosis. Despite growing interest, systematic investigation of entosis remains limited due to the labor‐intensive nature of manual identification and analysis. Computational approaches are, therefore, needed to enable scalable and reproducible entosis detection. In this study, we developed and evaluated five morphology‐driven deformable segmentation models alongside a YOLOv8 deep learning–based detection framework for automated entotic cell identification in BxPC3 (pancreatic) and MCF7 (breast) cancer cell lines. The deformable models were designed to capture complementary morphological characteristics, including entropy, spatial proximity, contour topology, and circularity. Comparative evaluation showed that deformable Models A and C achieved the highest sensitivity, with recall values ranging from 0.91 to 0.94 and F1‐scores between 0.81 and 0.83, demonstrating robust performance across heterogeneous entotic morphologies. YOLOv8 achieved high overall accuracy (0.97) and specificity (0.98), indicating strong background discrimination, but exhibited lower recall (0.65) and F 1‐score (0.59), reflecting a conservative detection profile under extreme class imbalance, where entotic events comprised approximately 1% of all observed cells. While deformable models provided higher sensitivity and detailed morphological segmentation, YOLOv8 offered advantages in computational efficiency and rapid inference. Together, these findings highlight the complementary strengths of morphology‐driven segmentation and deep learning–based detection, and support the future development of scalable hybrid frameworks for automated entosis analysis.

5 September 2025 in World Neurosurgery
Verified
Journal Article
Open access
JGJerzy Gregorczyk
Jerzy Gregorczyk
NFNegin Fani
Negin Fani
MBMikołaj Biegański
Mikołaj Biegański
JMJakub Mocarski
Jakub Mocarski
PKPawel Kowalczyk
Pawel Kowalczyk
MBMateusz Bielecki
Mateusz Bielecki
Anterior cervical discectomy and fusion (ACDF) is a common surgical procedure used to treat herniated discs, degenerative disc disease, and nerve root compression in the cervical spine. This systematic literature review aims to analyze the available literature on the incidence, risk factors, clinical considerations, and available therapies for spinal epidural hematoma (SEH) following ACDF. A systematic search was conducted in PubMed, Google Scholar, and Embase from database inception to June 18, 2025, following the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. The search yielded 71 studies without duplicates. After applying the inclusion and exclusion criteria, 5 studies were selected for the final analysis. The overall incidence of SEH following ACDF was 0.835%. Most patients presented with dyspnea, paraplegia, or quadriplegia. A meta-analysis of the 5 studies (n = 3246; 28 events) confirmed this incidence, with moderate heterogeneity. Management varied on the basis of symptom severity, hematoma size, and neurological impairment. Surgical decompression was the most common treatment, although some cases were managed conservatively with success. SEH onset ranged from within 24 hours postoperatively to several days after surgery. Although uncommon, SEH after ACDF carries significant clinical risks. Preventive measures may help mitigate its occurrence. However, the limited literature prevents a precise determination of the incidence and associated risk factors, including coagulation disorders. There is a clear need for large-scale prospective and retrospective studies with standardized reporting to more accurately define the incidence, identify risk factors, and determine the optimal management of SEH following ACDF.